Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_00675 |
| Species: | Homo sapiens |
| Position : | chr19:151500000-152500000 |
| Year: | 2023 |
| Title: | Enhancer remodeling activates NOTCH3 signaling to confer chemoresistance in advanced nasopharyngeal carcinoma |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | nasopharyngeal carcinoma |
| PMID: | 37563118 |
| MONDO: | MONDO:0005350 |
| Tissue: | Nasopharynx |
| Tissue Ontology ID: | UBERON:0001714 |
| Cell Source: | CNE-2 |
| CVCL ID: | CVCL_6889 |
| Cell Type: | nasopharyngeal carcinoma cell |
| Cell Ontology ID: | CL:0000069 |
| Experiment Type: | Enhancer activity assay, Functional perturbation assay |
| High Throughput Method: | ChIP-seq, RNA-seq |
| Low Throughput Method: | ChIP-RT-qPCR, RT-RT-qPCR, Western blot |
| Target gene : | NOTCH3 |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|